Literature DB >> 15459262

Facial eczema and sight-threatening glaucoma.

Jonathan J Ross1, Aby Jacob, Mark Batterbury.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15459262      PMCID： PMC1079619          DOI： 10.1177/0141076809701009

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  4 in total

1.  Glaucoma from topically applied steroids.

Authors:  C Zugerman; D Saunders; F Levit
Journal:  Arch Dermatol       Date:  1976-09

2.  Glaucoma following the application of corticosteroid to the skin of the eyelids.

Authors:  R B Cubey
Journal:  Br J Dermatol       Date:  1976-08       Impact factor: 9.302

3.  Extensive visual loss with topical facial steroids.

Authors:  R K Aggarwal; T Potamitis; N H Chong; M Guarro; P Shah; S Kheterpal
Journal:  Eye (Lond)       Date:  1993       Impact factor: 3.775

4.  Steroid induced glaucoma: a report of two cases with a review of morbidity and prescribing in general practice.

Authors:  R P Phillips; I C McLean; R J Taylor; J V Forrester
Journal:  Scott Med J       Date:  1990-06       Impact factor: 0.729
  4 in total
  3 in total

1.  Irreversible visual loss secondary to excessive topical steroid use in eczema.

Authors:  Charles Lim Fat; Thorfinn Leslie
Journal:  Br J Gen Pract       Date:  2011-09       Impact factor: 5.386

2.  Corticosteroids and open-angle glaucoma in the elderly: a population-based cohort study.

Authors:  Michael W Marcus; Rogier P H M Müskens; Wishal D Ramdas; Roger C W Wolfs; Paulus T V M De Jong; Johannes R Vingerling; Albert Hofman; Bruno H C Stricker; Nomdo M Jansonius
Journal:  Drugs Aging       Date:  2012-12       Impact factor: 3.923

3.  Retrospective analysis of ocular adverse events with Clobetasol.

Authors:  Yu Wang; Joseph L Jorizzo
Journal:  Dermatol Ther       Date:  2022-05-29       Impact factor: 3.858
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.